Sign in Join
  • Home
    • About Us
      • Privacy Policy
        • Disclaimer
    • Advertise On Market Exclusive
    • Sitemap
    • Submit a Scoop!
    • Contact Us
  • Stock Market News
  • Stocks
    • Analyst Ratings
    • Insider Trading
    • SEC Filings
    • Earnings
  • Cannabis Stocks News
  • Biotech Stocks
  • Small Caps
  • Blockchain & Cryptocurrency
  • Become a Contributor!
Sign in
Welcome!Log into your account
Forgot your password?
Sign up
Welcome!Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
Search
  • Sign in / Join
  • My Account
  • orders
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • Home
    • About Us
      • Privacy Policy
        • Disclaimer
    • Advertise On Market Exclusive
    • Sitemap
    • Submit a Scoop!
    • Contact Us
  • Stock Market News
  • Stocks
    • Analyst Ratings
    • Insider Trading
    • SEC Filings
    • Earnings
  • Cannabis Stocks News
  • Biotech Stocks
  • Small Caps
  • Blockchain & Cryptocurrency
  • Become a Contributor!
Home SEC Filings National CineMedia, Inc. (NASDAQ:NCMI) Files An 8-K Entry into a Material Definitive...
  • SEC Filings

National CineMedia, Inc. (NASDAQ:NCMI) Files An 8-K Entry into a Material Definitive Agreement

By
ME Staff 8-k
-
October 9, 2019
Share on Facebook
Tweet on Twitter

National CineMedia, Inc. (NASDAQ:NCMI) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01

5.875% Senior Secured Notes and Indenture
On October 8, 2019, National CineMedia, Inc.’s consolidated subsidiary, National CineMedia, LLC (“NCM LLC”), completed a private offering of $400.0 million aggregate principal amount of 5.875% senior secured notes due 2028 (the “2028 Notes”) to eligible purchasers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons in transactions outside the United States in compliance with Regulation S under the Securities Act. The 2028 Notes were issued at 50% of the face amount thereof.
The 2028 Notes were issued to an Indenture, dated as of October 8, 2019 (the “Indenture”), between NCM LLC and Wells Fargo Bank, National Association, as trustee (the “Trustee”). The 2028 Notes are senior secured obligations of NCM LLC, secured by a first priority security interest on substantially all of NCM LLC’s properties and assets that secure NCM LLC’s existing senior secured credit facility, which interests will be pari passu>with the interests securing NCM LLC’s existing senior secured credit facility. The Indenture also allows NCM LLC to enter into an asset backed loan facility (an “ABL Facility” and the obligations thereunder, the “ABL Obligations”) and provides that from the date of closing an ABL Facility, subject to certain exceptions, the ABL priority collateral will be granted to the holders of the ABL Obligations on a first priority basis and the remaining collateral will be granted to the holders of the ABL Obligations on a second-lien basis. The 2028 Notes rank equally in right of payment with NCM LLC’s existing and future senior indebtedness that is not subordinated in right of payment to the 2028 Notes, including NCM LLC’s existing senior secured credit facility, any future ABL Facility, and NCM LLC’s existing 5.750% senior notes due 2026 (the “2026 Notes”), in each case, without giving effect to collateral arrangements. The 2028 Notes will be effectively senior to NCM LLC’s existing and future senior unsecured indebtedness, including the 2026 Notes, and any obligations secured by permitted liens on the collateral ranking junior in priority to the liens on the collateral securing the 2028 Notes, to the extent of the value of the assets securing the 2028 Notes. The 2028 Notes will be effectively subordinated to any obligations that are secured by any of NCM LLC’s assets that are not part of the collateral for the 2028 Notes or that are secured by liens on the collateral ranking senior in priority to the liens on the collateral securing the 2028 Notes (including, if NCM LLC enters into an ABL Facility, with respect to the liens on NCM LLC’s accounts receivable and cash or cash equivalents), to the extent of the value of the assets securing the 2028 Notes.
The 2028 Notes will mature on April 15, 2028. Interest on the 2028 Notes accrues at a rate of 5.875% per annum and is payable semi-annually in arrears on April 15 and October 15 of each year, commencing on April 15, 2020. NCM LLC will pay interest to those persons who were holders of record at the close of business on the April 1 and October 1 immediately preceding the interest payment date.
At any time prior to April 15, 2023, NCM LLC may redeem all or any portion of the 2028 Notes at a redemption price equal to 50% of the principal amount plus the applicable premium, plus accrued and unpaid interest, if any, to the redemption date. On or after April 15, 2023, NCM LLC may redeem all or any portion of the 2028 Notes at specified redemption prices, plus accrued and unpaid interest, if any, to the redemption date. In addition, at any time prior to April 15, 2023, NCM LLC may on any one or more occasions redeem up to 35% of the original aggregate principal amount of the 2028 Notes from the net proceeds of certain equity offerings at a redemption price equal to 105.875% of the principal amount of the 2028 Notes redeemed, plus accrued and unpaid interest, if any, to the redemption date, provided that at least 65% of the original aggregate principal amount of the 2028 Notes remains outstanding after each such redemption and the redemption occurs within 90 days after the closing of such applicable equity offering.
Upon the occurrence of a Change of Control (as defined in the Indenture), NCM LLC will be required to make an offer to purchase all outstanding 2028 Notes at a purchase price equal to 101% of the principal amount of the 2028 Notes, plus accrued and unpaid interest, if any, to the date of repurchase.
The Indenture contains covenants that, among other things, restrict NCM LLC’s ability and the ability of its restricted subsidiaries, if any, to: (1) incur additional debt; (2) make distributions or make certain other restricted payments; (3) make certain investments; (4) incur certain liens; (5) sell assets or merge with or into other companies; and (6) enter into transactions with affiliates. All of these restrictive covenants are subject to a number of important exceptions and qualifications. In
particular, NCM LLC may distribute all of its quarterly available cash as a restricted payment or as an investment, provided that NCM LLC satisfies a minimum net senior secured leverage ratio.
The Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods), which include default in the payment of interest or principal when due, the breach of covenants contained in the Indenture, payment defaults or acceleration of other indebtedness, the failure to pay certain judgments, failure of liens securing the 2028 Notes to be enforceable or of the priority required and certain events of bankruptcy, insolvency or reorganization. Generally, if an event of default occurs, the Trustee or holders of at least 25% in aggregate principal amount of the then outstanding 2028 Notes may declare the principal of, premium, if any, and accrued but unpaid interest on all the 2028 Notes to be due and payable immediately. In the case of certain events of bankruptcy, insolvency or reorganization, all outstanding 2028 Notes will become due and payable immediately without further action or notice.
The foregoing description of the Indenture is qualified in its entirety by reference to the complete copy of the Indenture filed as Exhibit 4.1 to this Current Report on Form 8-K and incorporated by reference herein.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of Registrant.
The information provided in Item 1.01 of this Form 8-K concerning the Indenture and the 2028 Notes is hereby incorporated into this Item 2.03.
Item 2.04. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.
On October 8, 2019, NCM LLC called for redemption the entire $400.0 million aggregate principal amount outstanding of NCM LLC’s existing 6.00% senior secured notes due 2022 (the “2022 Notes”). The redemption price for the 2022 Notes is 101.000% of the principal amount thereof plus accrued and unpaid interest thereon, to but not including the redemption date. The redemption date will be November 7, 2019.
(d) Exhibits.
National CineMedia, Inc. Exhibit
EX-4.1 2 exhibit41.htm EX 4.1 Exhibit Exhibit 4.1 EXECUTION NATIONAL CINEMEDIA,…
To view the full exhibit click here

Story continues below

About National CineMedia, Inc. (NASDAQ:NCMI)

National CineMedia, Inc. (NCM, Inc.) is a holding company that manages its consolidated subsidiary National CineMedia, LLC (NCM LLC). NCM LLC operates the digital in-theatre media network in North America, through which it sells in-theatre and online advertising and promotions. The Company is engaged in advertising business. It operates through advertising segment. The Company’s advertising and entertainment pre-show, FirstLook, lobby entertainment network (LEN) and programming are distributed across its digital content network (DCN) utilizing its digital content software (DCS). NCM, Inc. has no business operations or material assets. Its on-screen digital FirstLook pre-feature show consists of national and local advertising, as well as behind the scenes making-of and other entertainment content provided by its content partners and other clients. The Company’s Lobby Entertainment Network (LEN) has approximately 3,104 screens in over 1,519 theatres connected to its DCN.

An ad to help with our costs
SHARE
Facebook
Twitter
ME Staff 8-k

RELATED ARTICLESMORE FROM AUTHOR

GROWLIFE, INC. (OTCMKTS:PHOT) Files An 8-K Financial Statements and Exhibits

BIOTRICITY INC. (OTCMKTS:BTCY) Files An 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Gladstone Capital Corporation (NASDAQ:GLAD) Files An 8-K Regulation FD Disclosure

Gladstone Investment Corporation (NASDAQ:GAIN) Files An 8-K Regulation FD Disclosure

NET 1 UEPS TECHNOLOGIES, INC. (NASDAQ:UEPS) Files An 8-K Entry into a Material Definitive Agreement

Cloud Peak Energy Inc. (NYSE:CLD) Files An 8-K Bankruptcy or Receivership

A word from the sponsor
Latest Articles
  • LIBERTY BROADBAND CORPORATION (NASDAQ:LBRDA) Files An 8-K Regulation FD Disclosure
  • REGENCY CENTERS CORPORATION (NYSE:REG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • ASSURED GUARANTY LTD. (NYSE:AGO) Files An 8-K Results of Operations and Financial Condition

Recent Posts

  • National CineMedia, Inc. (NASDAQ:NCMI) Files An 8-K Entry into a Material Definitive Agreement
  • Hollywood Bowl Group PLC (LON:BOWL) price target raised to GBX 270 by JPMorgan Chase & Co.
  • AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays with a GBX 8,200 price target
  • AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays
  • Anglo Pacific Group plc (LON:APF) had its Buy rating reiterated by Bank of America
Sponsored
/* */

EDITOR PICKS

Market Morning

Market Morning: Lam Threatens Hong Kong, Brexit Breakdown

October 8, 2019
Stock Market Roundup

Market Morning: Fed Repo Men, Free Trades, Cheese Hoarding, PayPal Bails...

October 7, 2019
cannabis-news

Cannabis Stock News Daily Roundup October 4

October 4, 2019

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings88918
  • Analyst Ratings21637
  • Insider Trading7542
  • Earnings4727
  • LSE4062
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1477
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019
// AST – IMS - [MarketExclusive_ROS]